A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Long-term weight loss for patients with obesity proved mostly successful after taking prescription-only injectable ...

There is no FDA-approved generic version of brand-name weight loss drugs since pharmaceutical companies still hold patents on ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

According to Grand View Research, the global market for beauty and personal care products is projected to increase at a CAGR ...

According to Fortune Business Insights, in 2023, the hair care industry was estimated to be worth $99.52 billion globally.

Novo Nordisk, the manufacturer behind Ozempic and Wegovy, has another weight loss medication in the works with some ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...